Previous Close | 0.1200 |
Open | 0.1150 |
Bid | 0.1150 x 0 |
Ask | 0.1200 x 0 |
Day's Range | 0.1150 - 0.1170 |
52 Week Range | 0.0450 - 0.1750 |
Volume | |
Avg. Volume | 294,073 |
Market Cap | 34.418M |
Beta (5Y Monthly) | 1.46 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings Date | Aug 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.50 |
With the business potentially at an important milestone, we thought we'd take a closer look at CardieX Limited's...
Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewed study validating its innovative method for measuring central aortic pressure—an important indicator of heart health—using a noninvasive fingertip sensor. The study, co-authored by Cardiex's team, was published in the respected journal Pulse.